A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

NCT00236613 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.